|FIOCRUZ AND UFRJ SIGN CONTRACT TO OPEN RESEARCH CENTER AT UFRJ SCIENCE PARK|
|On October 6, Oswaldo Cruz Foundation (Fiocruz) and the Federal University of Rio de Janeiro (UFRJ) signed a Concession of Use of an Area to install a research and technological development center on drugs at UFRJ Science Park.
Farmanguinhos/Fiocruz Reference Center in Drugs Synthesis will foster the development of Active Pharmaceutical Ingredients (IFAs - Insumos Farmacêuticos Ativos). First, the substances will be developed in laboratories and, later, as pilot projects focusing on the treatment of old diseases which affect the Brazilian population, such as malaria, schistosomiasis, leishmaniosis, among other neglected diseases.
Roberto Leher, Rector of UFRJ, Paulo Gadelha, President of Fiocruz, Hayne Felipe da Silva, CEO of Farmanguinhos/Fiocruz and José Carlos Pinto, CEO of the UFRJ Science Park were present at the signing ceremony.|
|MOBICARE IS NOW A NEW RESIDENT OF THE SCIENCE PARK |
|Mobicare, a company that operates in the telecommunication sector, is the most recent resident at the UFRJ Science Park. The company is specialized in solutions for mobile self-service and WiFi Carrier Grade. Graduated from the Genesis Institute at PUC-Rio, the company comes to the Park to participate in the post-incubation program, strengthening its R&D partnership with UFRJ, focusing on the networks area.
The Park’s post-incubation program aims at supporting the structuring and growth of these companies, as well as helping business articulation and innovation development.
The company now becomes part of the innovative environment of the Park, which currently houses research centers of 14 large companies, 9 small and medium-sized ones, 7 laboratories and 26 startups, residents at COPPE Business Incubator.|